Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 3 | Journal of Ophthalmic Inflammation and Infection

Fig. 3

From: Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease

Fig. 3

Patient 1 OS. Evolution of blue light fundus autofluorescence (BL-FAF). At presentation (A), numerous lines of BL-FAF bright hyperautofluorescence due to accumulation of lipofuscin products from progressing destruction of photoreceptors. Seven weeks later (B), slight decrease of bright hyperautofluorescent rims but apparition of newly affected areas. Four months later (C), substantial decrease of bright hyperautofluorescence at the border of lesions. One year later (D), hyperautofluorescent rims have almost completely disappeared indicating complete arrest of progression of lesions, confirmed 6 months later (E)

Back to article page